nodes	percent_of_prediction	percent_of_DWPC	metapath
Cholecalciferol—Vitamin D—Calcipotriol—psoriasis	0.293	1	CiPCiCtD
Cholecalciferol—Calcipotriol—psoriasis	0.123	0.569	CrCtD
Cholecalciferol—chronic kidney failure—Calcitriol—psoriasis	0.119	1	CpDpCtD
Cholecalciferol—Calcitriol—psoriasis	0.0933	0.431	CrCtD
Cholecalciferol—VDR—psoriasis	0.0774	1	CbGaD
Cholecalciferol—GC—Calcitriol—psoriasis	0.0497	0.379	CbGbCtD
Cholecalciferol—VDR—Calcipotriol—psoriasis	0.0336	0.256	CbGbCtD
Cholecalciferol—VDR—Calcitriol—psoriasis	0.0227	0.173	CbGbCtD
Cholecalciferol—Calcidiol—Calcipotriol—psoriasis	0.0138	0.0948	CrCrCtD
Cholecalciferol—Calcitriol—Calcipotriol—psoriasis	0.0138	0.0948	CrCrCtD
Cholecalciferol—Alfacalcidol—Calcipotriol—psoriasis	0.0138	0.0948	CrCrCtD
Cholecalciferol—Ergocalciferol—Calcipotriol—psoriasis	0.0138	0.0948	CrCrCtD
Cholecalciferol—Dihydrotachysterol—Calcipotriol—psoriasis	0.0138	0.0948	CrCrCtD
Cholecalciferol—Paricalcitol—Calcipotriol—psoriasis	0.0138	0.0948	CrCrCtD
Cholecalciferol—Paricalcitol—Calcitriol—psoriasis	0.0105	0.0719	CrCrCtD
Cholecalciferol—Calcidiol—Calcitriol—psoriasis	0.0105	0.0719	CrCrCtD
Cholecalciferol—Dihydrotachysterol—Calcitriol—psoriasis	0.0105	0.0719	CrCrCtD
Cholecalciferol—Calcipotriol—Calcitriol—psoriasis	0.0105	0.0719	CrCrCtD
Cholecalciferol—Ergocalciferol—Calcitriol—psoriasis	0.0105	0.0719	CrCrCtD
Cholecalciferol—Alfacalcidol—Calcitriol—psoriasis	0.0105	0.0719	CrCrCtD
Cholecalciferol—CYP1A1—Clobetasol propionate—psoriasis	0.00511	0.039	CbGbCtD
Cholecalciferol—CYP11A1—Dexamethasone—psoriasis	0.00306	0.0233	CbGbCtD
Cholecalciferol—CYP1A1—Methoxsalen—psoriasis	0.00269	0.0205	CbGbCtD
Cholecalciferol—CYP2C8—Tazarotene—psoriasis	0.00241	0.0183	CbGbCtD
Cholecalciferol—CYP2D6—Hydroxyurea—psoriasis	0.00108	0.00824	CbGbCtD
Cholecalciferol—CYP27A1—vertebral column—psoriasis	0.000956	0.297	CbGeAlD
Cholecalciferol—CYP2C8—Mycophenolate mofetil—psoriasis	0.00089	0.00679	CbGbCtD
Cholecalciferol—CYP3A4—Calcitriol—psoriasis	0.000809	0.00617	CbGbCtD
Cholecalciferol—CYP1A1—Dexamethasone—psoriasis	0.00077	0.00587	CbGbCtD
Cholecalciferol—CYP2C8—Hydrocortisone—psoriasis	0.000715	0.00545	CbGbCtD
Cholecalciferol—VDR—vertebral column—psoriasis	0.00069	0.214	CbGeAlD
Cholecalciferol—CYP2C8—Cyclosporine—psoriasis	0.000675	0.00515	CbGbCtD
Cholecalciferol—CYP3A4—Methoxsalen—psoriasis	0.000629	0.00479	CbGbCtD
Cholecalciferol—CYP2C19—Prednisone—psoriasis	0.000597	0.00455	CbGbCtD
Cholecalciferol—CYP2B6—Dexamethasone—psoriasis	0.000587	0.00447	CbGbCtD
Cholecalciferol—CYP2C19—Cyclosporine—psoriasis	0.000566	0.00432	CbGbCtD
Cholecalciferol—CYP2C9—Cyclosporine—psoriasis	0.000471	0.00359	CbGbCtD
Cholecalciferol—CYP2C8—Dexamethasone—psoriasis	0.000444	0.00339	CbGbCtD
Cholecalciferol—CYP2D6—Cyclosporine—psoriasis	0.00043	0.00328	CbGbCtD
Cholecalciferol—VDR—skin epidermis—psoriasis	0.000423	0.131	CbGeAlD
Cholecalciferol—CYP2C19—Dexamethasone—psoriasis	0.000373	0.00284	CbGbCtD
Cholecalciferol—CYP3A4—Mycophenolate mofetil—psoriasis	0.000361	0.00275	CbGbCtD
Cholecalciferol—CYP3A4—Triamcinolone—psoriasis	0.000361	0.00275	CbGbCtD
Cholecalciferol—CDC25A—Calcipotriol—Calcitriol—psoriasis	0.000357	0.82	CbGdCrCtD
Cholecalciferol—CYP2C9—Dexamethasone—psoriasis	0.00031	0.00236	CbGbCtD
Cholecalciferol—CYP3A4—Betamethasone—psoriasis	0.00031	0.00236	CbGbCtD
Cholecalciferol—CYP3A4—Prednisolone—psoriasis	0.000306	0.00233	CbGbCtD
Cholecalciferol—CYP3A4—Hydrocortisone—psoriasis	0.00029	0.00221	CbGbCtD
Cholecalciferol—CYP3A4—Prednisone—psoriasis	0.000289	0.0022	CbGbCtD
Cholecalciferol—CYP2D6—Dexamethasone—psoriasis	0.000283	0.00216	CbGbCtD
Cholecalciferol—CYP3A4—Cyclosporine—psoriasis	0.000274	0.00209	CbGbCtD
Cholecalciferol—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.000243	0.0198	CbGpPWpGaD
Cholecalciferol—Dihydrotachysterol—VDR—psoriasis	0.000232	0.22	CrCbGaD
Cholecalciferol—CYP27A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00022	0.018	CbGpPWpGaD
Cholecalciferol—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000212	0.0173	CbGpPWpGaD
Cholecalciferol—CDC25A—G1/S-Specific Transcription—PCNA—psoriasis	0.00021	0.0171	CbGpPWpGaD
Cholecalciferol—CYP2J2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00021	0.0171	CbGpPWpGaD
Cholecalciferol—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.000206	0.0168	CbGpPWpGaD
Cholecalciferol—CYP1A1—skin epidermis—psoriasis	0.000193	0.0598	CbGeAlD
Cholecalciferol—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.000184	0.015	CbGpPWpGaD
Cholecalciferol—CYP27A1—skin of body—psoriasis	0.000182	0.0564	CbGeAlD
Cholecalciferol—CYP3A4—Dexamethasone—psoriasis	0.00018	0.00137	CbGbCtD
Cholecalciferol—CYP2J2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000172	0.014	CbGpPWpGaD
Cholecalciferol—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.000169	0.0138	CbGpPWpGaD
Cholecalciferol—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.000168	0.0137	CbGpPWpGaD
Cholecalciferol—CYP2J2—skin of body—psoriasis	0.000166	0.0515	CbGeAlD
Cholecalciferol—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.000158	0.0128	CbGpPWpGaD
Cholecalciferol—CDC25A—G0 and Early G1—PCNA—psoriasis	0.000154	0.0126	CbGpPWpGaD
Cholecalciferol—CYP2R1—Biological oxidations—CYP2S1—psoriasis	0.000152	0.0124	CbGpPWpGaD
Cholecalciferol—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.000151	0.0123	CbGpPWpGaD
Cholecalciferol—CYP2R1—Metapathway biotransformation—CYP2S1—psoriasis	0.00015	0.0122	CbGpPWpGaD
Cholecalciferol—Calcidiol—VDR—psoriasis	0.00015	0.142	CrCbGaD
Cholecalciferol—Alfacalcidol—VDR—psoriasis	0.00015	0.142	CrCbGaD
Cholecalciferol—Calcipotriol—VDR—psoriasis	0.00015	0.142	CrCbGaD
Cholecalciferol—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000147	0.012	CbGpPWpGaD
Cholecalciferol—CYP11A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000145	0.0118	CbGpPWpGaD
Cholecalciferol—CYP1A1—Xenobiotics—CYP2S1—psoriasis	0.000139	0.0113	CbGpPWpGaD
Cholecalciferol—CYP27A1—tendon—psoriasis	0.000138	0.0429	CbGeAlD
Cholecalciferol—Calcitriol—VDR—psoriasis	0.000133	0.126	CrCbGaD
Cholecalciferol—Paricalcitol—VDR—psoriasis	0.000133	0.126	CrCbGaD
Cholecalciferol—VDR—skin of body—psoriasis	0.000131	0.0407	CbGeAlD
Cholecalciferol—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.000128	0.0104	CbGpPWpGaD
Cholecalciferol—CYP2J2—tendon—psoriasis	0.000126	0.0392	CbGeAlD
Cholecalciferol—CDC25A—E2F mediated regulation of DNA replication—PCNA—psoriasis	0.000124	0.0101	CbGpPWpGaD
Cholecalciferol—CYP11A1—Corticotropin-releasing hormone—IVL—psoriasis	0.000123	0.01	CbGpPWpGaD
Cholecalciferol—CDC25A—Cell Cycle—PTTG1—psoriasis	0.000123	0.01	CbGpPWpGaD
Cholecalciferol—CYP11A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000119	0.00972	CbGpPWpGaD
Cholecalciferol—CYP27A1—Biological oxidations—CYP2S1—psoriasis	0.000117	0.00954	CbGpPWpGaD
Cholecalciferol—CYP27A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000116	0.00941	CbGpPWpGaD
Cholecalciferol—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000114	0.00928	CbGpPWpGaD
Cholecalciferol—CDC25A—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000107	0.00873	CbGpPWpGaD
Cholecalciferol—Ergocalciferol—VDR—psoriasis	0.000107	0.101	CrCbGaD
Cholecalciferol—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000105	0.00854	CbGpPWpGaD
Cholecalciferol—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000104	0.00846	CbGpPWpGaD
Cholecalciferol—VDR—tendon—psoriasis	9.98e-05	0.031	CbGeAlD
Cholecalciferol—CYP2J2—Biological oxidations—CYP2S1—psoriasis	9.14e-05	0.00745	CbGpPWpGaD
Cholecalciferol—CYP2J2—Metapathway biotransformation—CYP2S1—psoriasis	9.02e-05	0.00735	CbGpPWpGaD
Cholecalciferol—CDC25A—ATM Signaling Pathway—NFKBIA—psoriasis	8.9e-05	0.00725	CbGpPWpGaD
Cholecalciferol—CDC25A—miRNAs involved in DNA damage response—TP53—psoriasis	8.54e-05	0.00696	CbGpPWpGaD
Cholecalciferol—VDR—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	8.3e-05	0.00676	CbGpPWpGaD
Cholecalciferol—CYP2J2—Tryptophan metabolism—CAT—psoriasis	7.89e-05	0.00643	CbGpPWpGaD
Cholecalciferol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	7.29e-05	0.00594	CbGpPWpGaD
Cholecalciferol—CDC25A—G1 to S cell cycle control—PCNA—psoriasis	6.93e-05	0.00565	CbGpPWpGaD
Cholecalciferol—CYP3A4—Xenobiotics—CYP2S1—psoriasis	6.85e-05	0.00558	CbGpPWpGaD
Cholecalciferol—CYP11A1—Biological oxidations—CYP2S1—psoriasis	6.34e-05	0.00516	CbGpPWpGaD
Cholecalciferol—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	6.26e-05	0.0051	CbGpPWpGaD
Cholecalciferol—CYP11A1—Metapathway biotransformation—CYP2S1—psoriasis	6.25e-05	0.00509	CbGpPWpGaD
Cholecalciferol—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	6.18e-05	0.00503	CbGpPWpGaD
Cholecalciferol—CYP1A1—skin of body—psoriasis	5.97e-05	0.0185	CbGeAlD
Cholecalciferol—CDC25A—ATM Signaling Pathway—JUN—psoriasis	5.9e-05	0.00481	CbGpPWpGaD
Cholecalciferol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.88e-05	0.00479	CbGpPWpGaD
Cholecalciferol—CYP2B6—skin of body—psoriasis	5.8e-05	0.018	CbGeAlD
Cholecalciferol—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	5.78e-05	0.00471	CbGpPWpGaD
Cholecalciferol—CYP1A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	5.71e-05	0.00465	CbGpPWpGaD
Cholecalciferol—CDC25A—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	5.69e-05	0.00464	CbGpPWpGaD
Cholecalciferol—VDR—Nuclear Receptors—PPARG—psoriasis	5.38e-05	0.00439	CbGpPWpGaD
Cholecalciferol—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	5.3e-05	0.00432	CbGpPWpGaD
Cholecalciferol—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	5.23e-05	0.00426	CbGpPWpGaD
Cholecalciferol—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	5.08e-05	0.00414	CbGpPWpGaD
Cholecalciferol—CDC25A—Cell Cycle—PCNA—psoriasis	5.01e-05	0.00408	CbGpPWpGaD
Cholecalciferol—CDC25A—G1/S Transition—PCNA—psoriasis	4.75e-05	0.00387	CbGpPWpGaD
Cholecalciferol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	4.73e-05	0.00385	CbGpPWpGaD
Cholecalciferol—CYP1A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	4.69e-05	0.00382	CbGpPWpGaD
Cholecalciferol—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	4.67e-05	0.0038	CbGpPWpGaD
Cholecalciferol—VDR—Direct p53 effectors—CARM1—psoriasis	4.56e-05	0.00371	CbGpPWpGaD
Cholecalciferol—VDR—Direct p53 effectors—TGFA—psoriasis	4.56e-05	0.00371	CbGpPWpGaD
Cholecalciferol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	4.35e-05	0.00355	CbGpPWpGaD
Cholecalciferol—CDC25A—S Phase—PCNA—psoriasis	4.31e-05	0.00352	CbGpPWpGaD
Cholecalciferol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	4.31e-05	0.00351	CbGpPWpGaD
Cholecalciferol—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	4.3e-05	0.0035	CbGpPWpGaD
Cholecalciferol—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	4.29e-05	0.0035	CbGpPWpGaD
Cholecalciferol—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	4.26e-05	0.00347	CbGpPWpGaD
Cholecalciferol—VDR—Nuclear Receptor transcription pathway—PPARG—psoriasis	4.25e-05	0.00347	CbGpPWpGaD
Cholecalciferol—CDC25A—Danazol—Hydrocortisone—psoriasis	4.2e-05	0.0965	CbGdCrCtD
Cholecalciferol—VDR—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	4.1e-05	0.00334	CbGpPWpGaD
Cholecalciferol—CDC25A—Mitotic G1-G1/S phases—PCNA—psoriasis	4e-05	0.00326	CbGpPWpGaD
Cholecalciferol—CDC25A—ATM Signaling Pathway—TP53—psoriasis	3.9e-05	0.00317	CbGpPWpGaD
Cholecalciferol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	3.87e-05	0.00316	CbGpPWpGaD
Cholecalciferol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	3.84e-05	0.00313	CbGpPWpGaD
Cholecalciferol—CDC25A—Danazol—Prednisone—psoriasis	3.62e-05	0.0831	CbGdCrCtD
Cholecalciferol—CDC25A—Integrated Cancer Pathway—TP53—psoriasis	3.61e-05	0.00294	CbGpPWpGaD
Cholecalciferol—CDC25A—Cell Cycle, Mitotic—PTTG1—psoriasis	3.6e-05	0.00294	CbGpPWpGaD
Cholecalciferol—GC—Metabolism—NDUFA5—psoriasis	3.56e-05	0.0029	CbGpPWpGaD
Cholecalciferol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	3.53e-05	0.00287	CbGpPWpGaD
Cholecalciferol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	3.5e-05	0.00285	CbGpPWpGaD
Cholecalciferol—GC—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.32e-05	0.0027	CbGpPWpGaD
Cholecalciferol—CDC25A—Cell Cycle—PTTG1—psoriasis	3.22e-05	0.00263	CbGpPWpGaD
Cholecalciferol—CYP2R1—Metabolism—NDUFA5—psoriasis	3.05e-05	0.00249	CbGpPWpGaD
Cholecalciferol—CYP1A1—Oxidative Stress—CAT—psoriasis	3.02e-05	0.00246	CbGpPWpGaD
Cholecalciferol—GC—Metabolism—CYP2S1—psoriasis	3.02e-05	0.00246	CbGpPWpGaD
Cholecalciferol—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	2.88e-05	0.00234	CbGpPWpGaD
Cholecalciferol—CDC25A—G1/S DNA Damage Checkpoints—TP53—psoriasis	2.86e-05	0.00233	CbGpPWpGaD
Cholecalciferol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	2.85e-05	0.00232	CbGpPWpGaD
Cholecalciferol—CYP2R1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.84e-05	0.00232	CbGpPWpGaD
Cholecalciferol—CYP1A1—Estrogen Receptor Pathway—JUN—psoriasis	2.83e-05	0.00231	CbGpPWpGaD
Cholecalciferol—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	2.81e-05	0.00229	CbGpPWpGaD
Cholecalciferol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	2.77e-05	0.00226	CbGpPWpGaD
Cholecalciferol—VDR—Gene Expression—TARS—psoriasis	2.7e-05	0.0022	CbGpPWpGaD
Cholecalciferol—CYP2B6—Biological oxidations—CYP2S1—psoriasis	2.7e-05	0.0022	CbGpPWpGaD
Cholecalciferol—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	2.66e-05	0.00217	CbGpPWpGaD
Cholecalciferol—CYP2R1—Metabolism—CYP2S1—psoriasis	2.59e-05	0.00211	CbGpPWpGaD
Cholecalciferol—CDC25A—DNA Damage Response—TP53—psoriasis	2.55e-05	0.00208	CbGpPWpGaD
Cholecalciferol—CDC25A—G1 to S cell cycle control—TP53—psoriasis	2.55e-05	0.00208	CbGpPWpGaD
Cholecalciferol—CYP1A1—Biological oxidations—CYP2S1—psoriasis	2.49e-05	0.00203	CbGpPWpGaD
Cholecalciferol—CDC25A—miRNA Regulation of DNA Damage Response—TP53—psoriasis	2.46e-05	0.00201	CbGpPWpGaD
Cholecalciferol—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	2.46e-05	0.002	CbGpPWpGaD
Cholecalciferol—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	2.45e-05	0.002	CbGpPWpGaD
Cholecalciferol—VDR—Direct p53 effectors—PCNA—psoriasis	2.41e-05	0.00197	CbGpPWpGaD
Cholecalciferol—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	2.41e-05	0.00197	CbGpPWpGaD
Cholecalciferol—CYP27A1—Metabolism—NDUFA5—psoriasis	2.36e-05	0.00192	CbGpPWpGaD
Cholecalciferol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	2.31e-05	0.00188	CbGpPWpGaD
Cholecalciferol—CYP2C8—Biological oxidations—CYP2S1—psoriasis	2.28e-05	0.00186	CbGpPWpGaD
Cholecalciferol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	2.28e-05	0.00185	CbGpPWpGaD
Cholecalciferol—CYP11A1—Corticotropin-releasing hormone—NFKBIA—psoriasis	2.27e-05	0.00185	CbGpPWpGaD
Cholecalciferol—CDC25A—Validated targets of C-MYC transcriptional activation—TP53—psoriasis	2.26e-05	0.00184	CbGpPWpGaD
Cholecalciferol—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	2.25e-05	0.00183	CbGpPWpGaD
Cholecalciferol—CYP27A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.2e-05	0.00179	CbGpPWpGaD
Cholecalciferol—CYP1A1—Tryptophan metabolism—CAT—psoriasis	2.15e-05	0.00175	CbGpPWpGaD
Cholecalciferol—CDC25A—Retinoblastoma (RB) in Cancer—TP53—psoriasis	2.09e-05	0.00171	CbGpPWpGaD
Cholecalciferol—VDR—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	2.08e-05	0.0017	CbGpPWpGaD
Cholecalciferol—CDC25A—Integrated Breast Cancer Pathway—JUN—psoriasis	2.04e-05	0.00166	CbGpPWpGaD
Cholecalciferol—CYP2C19—Biological oxidations—CYP2S1—psoriasis	2.04e-05	0.00166	CbGpPWpGaD
Cholecalciferol—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	2.01e-05	0.00164	CbGpPWpGaD
Cholecalciferol—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2e-05	0.00163	CbGpPWpGaD
Cholecalciferol—CYP27A1—Metabolism—CYP2S1—psoriasis	2e-05	0.00163	CbGpPWpGaD
Cholecalciferol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	1.98e-05	0.00161	CbGpPWpGaD
Cholecalciferol—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	1.98e-05	0.00161	CbGpPWpGaD
Cholecalciferol—CDC25A—Integrated Breast Cancer Pathway—NFKB1—psoriasis	1.96e-05	0.0016	CbGpPWpGaD
Cholecalciferol—CYP2D6—Biological oxidations—CYP2S1—psoriasis	1.87e-05	0.00153	CbGpPWpGaD
Cholecalciferol—CYP2C9—Biological oxidations—CYP2S1—psoriasis	1.86e-05	0.00151	CbGpPWpGaD
Cholecalciferol—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	1.85e-05	0.00151	CbGpPWpGaD
Cholecalciferol—CDC25A—Cell Cycle—TP53—psoriasis	1.84e-05	0.0015	CbGpPWpGaD
Cholecalciferol—CYP2J2—Metabolism—NDUFA5—psoriasis	1.84e-05	0.0015	CbGpPWpGaD
Cholecalciferol—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	1.83e-05	0.00149	CbGpPWpGaD
Cholecalciferol—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	1.82e-05	0.00148	CbGpPWpGaD
Cholecalciferol—CDC25A—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1.78e-05	0.00145	CbGpPWpGaD
Cholecalciferol—VDR—Generic Transcription Pathway—CARM1—psoriasis	1.76e-05	0.00144	CbGpPWpGaD
Cholecalciferol—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	1.74e-05	0.00142	CbGpPWpGaD
Cholecalciferol—CYP2J2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.71e-05	0.0014	CbGpPWpGaD
Cholecalciferol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	1.7e-05	0.00139	CbGpPWpGaD
Cholecalciferol—CDC25A—Cell Cycle Checkpoints—TP53—psoriasis	1.65e-05	0.00135	CbGpPWpGaD
Cholecalciferol—CYP11A1—Corticotropin-releasing hormone—CXCL8—psoriasis	1.62e-05	0.00132	CbGpPWpGaD
Cholecalciferol—GC—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.58e-05	0.00129	CbGpPWpGaD
Cholecalciferol—CYP2J2—Metabolism—CYP2S1—psoriasis	1.56e-05	0.00127	CbGpPWpGaD
Cholecalciferol—GC—Metabolism—CARM1—psoriasis	1.48e-05	0.0012	CbGpPWpGaD
Cholecalciferol—CDC25A—Cell Cycle, Mitotic—PCNA—psoriasis	1.47e-05	0.0012	CbGpPWpGaD
Cholecalciferol—CYP11A1—Corticotropin-releasing hormone—NFKB1—psoriasis	1.45e-05	0.00118	CbGpPWpGaD
Cholecalciferol—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	1.44e-05	0.00117	CbGpPWpGaD
Cholecalciferol—CYP1A1—Oxidative Stress—NFKB1—psoriasis	1.4e-05	0.00114	CbGpPWpGaD
Cholecalciferol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.38e-05	0.00113	CbGpPWpGaD
Cholecalciferol—GC—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.38e-05	0.00112	CbGpPWpGaD
Cholecalciferol—CYP2R1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.36e-05	0.00111	CbGpPWpGaD
Cholecalciferol—CDC25A—Integrated Breast Cancer Pathway—TP53—psoriasis	1.35e-05	0.0011	CbGpPWpGaD
Cholecalciferol—VDR—Direct p53 effectors—JUN—psoriasis	1.34e-05	0.0011	CbGpPWpGaD
Cholecalciferol—CDC25A—Cell Cycle—PCNA—psoriasis	1.31e-05	0.00107	CbGpPWpGaD
Cholecalciferol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	1.31e-05	0.00106	CbGpPWpGaD
Cholecalciferol—CYP11A1—Metabolism—NDUFA5—psoriasis	1.27e-05	0.00104	CbGpPWpGaD
Cholecalciferol—CYP2R1—Metabolism—CARM1—psoriasis	1.27e-05	0.00103	CbGpPWpGaD
Cholecalciferol—CYP3A4—Biological oxidations—CYP2S1—psoriasis	1.23e-05	0.000998	CbGpPWpGaD
Cholecalciferol—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	1.21e-05	0.000985	CbGpPWpGaD
Cholecalciferol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	1.19e-05	0.000972	CbGpPWpGaD
Cholecalciferol—CYP11A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.19e-05	0.000968	CbGpPWpGaD
Cholecalciferol—CYP2R1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.18e-05	0.000965	CbGpPWpGaD
Cholecalciferol—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	1.17e-05	0.000957	CbGpPWpGaD
Cholecalciferol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	1.17e-05	0.000955	CbGpPWpGaD
Cholecalciferol—CYP11A1—Metabolism—CYP2S1—psoriasis	1.08e-05	0.000883	CbGpPWpGaD
Cholecalciferol—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	1.08e-05	0.00088	CbGpPWpGaD
Cholecalciferol—CYP3A4—Tryptophan metabolism—CAT—psoriasis	1.06e-05	0.000861	CbGpPWpGaD
Cholecalciferol—CYP27A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.05e-05	0.000855	CbGpPWpGaD
Cholecalciferol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	1.03e-05	0.00084	CbGpPWpGaD
Cholecalciferol—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	9.93e-06	0.000809	CbGpPWpGaD
Cholecalciferol—CYP27A1—Metabolism—CARM1—psoriasis	9.78e-06	0.000797	CbGpPWpGaD
Cholecalciferol—CYP27A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.14e-06	0.000745	CbGpPWpGaD
Cholecalciferol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.11e-06	0.000742	CbGpPWpGaD
Cholecalciferol—GC—Metabolism—CAT—psoriasis	9.08e-06	0.00074	CbGpPWpGaD
Cholecalciferol—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	9.01e-06	0.000734	CbGpPWpGaD
Cholecalciferol—VDR—Direct p53 effectors—TP53—psoriasis	8.88e-06	0.000723	CbGpPWpGaD
Cholecalciferol—VDR—Gene Expression—CARM1—psoriasis	8.5e-06	0.000692	CbGpPWpGaD
Cholecalciferol—CYP2J2—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.19e-06	0.000668	CbGpPWpGaD
Cholecalciferol—CYP2R1—Metabolism—CAT—psoriasis	7.79e-06	0.000635	CbGpPWpGaD
Cholecalciferol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	7.72e-06	0.000629	CbGpPWpGaD
Cholecalciferol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	7.72e-06	0.000629	CbGpPWpGaD
Cholecalciferol—CYP2J2—Metabolism—CARM1—psoriasis	7.64e-06	0.000622	CbGpPWpGaD
Cholecalciferol—VDR—Generic Transcription Pathway—PPARG—psoriasis	7.35e-06	0.000599	CbGpPWpGaD
Cholecalciferol—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	7.24e-06	0.00059	CbGpPWpGaD
Cholecalciferol—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.14e-06	0.000582	CbGpPWpGaD
Cholecalciferol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	7.08e-06	0.000577	CbGpPWpGaD
Cholecalciferol—GC—Metabolism—APOE—psoriasis	7.06e-06	0.000575	CbGpPWpGaD
Cholecalciferol—GC—Metabolism—PPARG—psoriasis	6.15e-06	0.000501	CbGpPWpGaD
Cholecalciferol—CYP2R1—Metabolism—APOE—psoriasis	6.05e-06	0.000493	CbGpPWpGaD
Cholecalciferol—CYP27A1—Metabolism—CAT—psoriasis	6.02e-06	0.00049	CbGpPWpGaD
Cholecalciferol—CYP11A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.68e-06	0.000463	CbGpPWpGaD
Cholecalciferol—CYP2B6—Metabolism—NDUFA5—psoriasis	5.42e-06	0.000442	CbGpPWpGaD
Cholecalciferol—CYP11A1—Metabolism—CARM1—psoriasis	5.29e-06	0.000431	CbGpPWpGaD
Cholecalciferol—CYP2R1—Metabolism—PPARG—psoriasis	5.27e-06	0.00043	CbGpPWpGaD
Cholecalciferol—CYP1A1—Metabolism—NDUFA5—psoriasis	5.01e-06	0.000408	CbGpPWpGaD
Cholecalciferol—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.95e-06	0.000403	CbGpPWpGaD
Cholecalciferol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	4.88e-06	0.000398	CbGpPWpGaD
Cholecalciferol—CDC25A—Cell Cycle—TP53—psoriasis	4.83e-06	0.000393	CbGpPWpGaD
Cholecalciferol—CYP2J2—Metabolism—CAT—psoriasis	4.7e-06	0.000383	CbGpPWpGaD
Cholecalciferol—CYP27A1—Metabolism—APOE—psoriasis	4.67e-06	0.000381	CbGpPWpGaD
Cholecalciferol—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.67e-06	0.00038	CbGpPWpGaD
Cholecalciferol—CYP2B6—Metabolism—CYP2S1—psoriasis	4.61e-06	0.000376	CbGpPWpGaD
Cholecalciferol—CYP2C8—Metabolism—NDUFA5—psoriasis	4.59e-06	0.000374	CbGpPWpGaD
Cholecalciferol—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.28e-06	0.000349	CbGpPWpGaD
Cholecalciferol—CYP1A1—Metabolism—CYP2S1—psoriasis	4.26e-06	0.000347	CbGpPWpGaD
Cholecalciferol—CYP2C19—Metabolism—NDUFA5—psoriasis	4.1e-06	0.000334	CbGpPWpGaD
Cholecalciferol—CYP27A1—Metabolism—PPARG—psoriasis	4.07e-06	0.000332	CbGpPWpGaD
Cholecalciferol—CYP2C8—Metabolism—CYP2S1—psoriasis	3.9e-06	0.000318	CbGpPWpGaD
Cholecalciferol—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.82e-06	0.000311	CbGpPWpGaD
Cholecalciferol—CYP2D6—Metabolism—NDUFA5—psoriasis	3.77e-06	0.000307	CbGpPWpGaD
Cholecalciferol—CYP2C9—Metabolism—NDUFA5—psoriasis	3.74e-06	0.000304	CbGpPWpGaD
Cholecalciferol—CYP2J2—Metabolism—APOE—psoriasis	3.65e-06	0.000297	CbGpPWpGaD
Cholecalciferol—VDR—Gene Expression—PPARG—psoriasis	3.54e-06	0.000288	CbGpPWpGaD
Cholecalciferol—CYP2C19—Metabolism—CYP2S1—psoriasis	3.48e-06	0.000284	CbGpPWpGaD
Cholecalciferol—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.48e-06	0.000284	CbGpPWpGaD
Cholecalciferol—CYP11A1—Metabolism—CAT—psoriasis	3.26e-06	0.000265	CbGpPWpGaD
Cholecalciferol—CYP2D6—Metabolism—CYP2S1—psoriasis	3.2e-06	0.000261	CbGpPWpGaD
Cholecalciferol—CYP2J2—Metabolism—PPARG—psoriasis	3.18e-06	0.000259	CbGpPWpGaD
Cholecalciferol—CYP2C9—Metabolism—CYP2S1—psoriasis	3.18e-06	0.000259	CbGpPWpGaD
Cholecalciferol—CYP11A1—Metabolism—APOE—psoriasis	2.53e-06	0.000206	CbGpPWpGaD
Cholecalciferol—CYP3A4—Metabolism—NDUFA5—psoriasis	2.46e-06	0.000201	CbGpPWpGaD
Cholecalciferol—CYP2B6—Metabolism—CARM1—psoriasis	2.25e-06	0.000183	CbGpPWpGaD
Cholecalciferol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.23e-06	0.000182	CbGpPWpGaD
Cholecalciferol—CYP11A1—Metabolism—PPARG—psoriasis	2.2e-06	0.00018	CbGpPWpGaD
Cholecalciferol—CYP3A4—Metabolism—CYP2S1—psoriasis	2.1e-06	0.000171	CbGpPWpGaD
Cholecalciferol—CYP1A1—Metabolism—CARM1—psoriasis	2.08e-06	0.000169	CbGpPWpGaD
Cholecalciferol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.05e-06	0.000167	CbGpPWpGaD
Cholecalciferol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.94e-06	0.000158	CbGpPWpGaD
Cholecalciferol—CYP2C8—Metabolism—CARM1—psoriasis	1.91e-06	0.000155	CbGpPWpGaD
Cholecalciferol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.83e-06	0.000149	CbGpPWpGaD
Cholecalciferol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.78e-06	0.000145	CbGpPWpGaD
Cholecalciferol—CYP2C19—Metabolism—CARM1—psoriasis	1.7e-06	0.000139	CbGpPWpGaD
Cholecalciferol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.66e-06	0.000136	CbGpPWpGaD
Cholecalciferol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.59e-06	0.00013	CbGpPWpGaD
Cholecalciferol—CYP2D6—Metabolism—CARM1—psoriasis	1.57e-06	0.000128	CbGpPWpGaD
Cholecalciferol—CYP2C9—Metabolism—CARM1—psoriasis	1.55e-06	0.000126	CbGpPWpGaD
Cholecalciferol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.45e-06	0.000118	CbGpPWpGaD
Cholecalciferol—CYP2B6—Metabolism—CAT—psoriasis	1.38e-06	0.000113	CbGpPWpGaD
Cholecalciferol—CYP1A1—Metabolism—CAT—psoriasis	1.28e-06	0.000104	CbGpPWpGaD
Cholecalciferol—CYP2C8—Metabolism—CAT—psoriasis	1.17e-06	9.55e-05	CbGpPWpGaD
Cholecalciferol—CYP2B6—Metabolism—APOE—psoriasis	1.08e-06	8.77e-05	CbGpPWpGaD
Cholecalciferol—CYP2C19—Metabolism—CAT—psoriasis	1.05e-06	8.53e-05	CbGpPWpGaD
Cholecalciferol—CYP3A4—Metabolism—CARM1—psoriasis	1.02e-06	8.34e-05	CbGpPWpGaD
Cholecalciferol—CYP1A1—Metabolism—APOE—psoriasis	9.94e-07	8.1e-05	CbGpPWpGaD
Cholecalciferol—CYP2D6—Metabolism—CAT—psoriasis	9.63e-07	7.84e-05	CbGpPWpGaD
Cholecalciferol—CYP2C9—Metabolism—CAT—psoriasis	9.54e-07	7.78e-05	CbGpPWpGaD
Cholecalciferol—CYP2B6—Metabolism—PPARG—psoriasis	9.37e-07	7.64e-05	CbGpPWpGaD
Cholecalciferol—CYP2C8—Metabolism—APOE—psoriasis	9.11e-07	7.42e-05	CbGpPWpGaD
Cholecalciferol—CYP1A1—Metabolism—PPARG—psoriasis	8.66e-07	7.05e-05	CbGpPWpGaD
Cholecalciferol—CYP2C19—Metabolism—APOE—psoriasis	8.13e-07	6.63e-05	CbGpPWpGaD
Cholecalciferol—CYP2C8—Metabolism—PPARG—psoriasis	7.94e-07	6.47e-05	CbGpPWpGaD
Cholecalciferol—CYP2D6—Metabolism—APOE—psoriasis	7.48e-07	6.09e-05	CbGpPWpGaD
Cholecalciferol—CYP2C9—Metabolism—APOE—psoriasis	7.41e-07	6.04e-05	CbGpPWpGaD
Cholecalciferol—CYP2C19—Metabolism—PPARG—psoriasis	7.08e-07	5.77e-05	CbGpPWpGaD
Cholecalciferol—CYP2D6—Metabolism—PPARG—psoriasis	6.51e-07	5.31e-05	CbGpPWpGaD
Cholecalciferol—CYP2C9—Metabolism—PPARG—psoriasis	6.46e-07	5.26e-05	CbGpPWpGaD
Cholecalciferol—CYP3A4—Metabolism—CAT—psoriasis	6.29e-07	5.13e-05	CbGpPWpGaD
Cholecalciferol—CYP3A4—Metabolism—APOE—psoriasis	4.89e-07	3.98e-05	CbGpPWpGaD
Cholecalciferol—CYP3A4—Metabolism—PPARG—psoriasis	4.26e-07	3.47e-05	CbGpPWpGaD
